SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-21-000391
Filing Date
2021-01-13
Accepted
2021-01-13 17:29:58
Documents
2
Period of Report
2020-12-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A azrx8ka_jan132021.htm 8-K/A 25379
2 LICENSE AGREEMENT BY AND BETWEEN THE COMPANY AND FIRST WAVE BIO, INC. ex10-1.htm EX-10.1 869652
  Complete submission text file 0001654954-21-000391.txt   896224
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37853 | Film No.: 21526905
SIC: 2834 Pharmaceutical Preparations